Digital photography combined with artificial intelligence technology has shown promising results as a diagnostic tool for the early detection of melanoma.

Australia and The Netherlands have an alarming statistic in common – melanoma is in their top five most diagnosed cancers. Clinical teams from both countries are now contributing to the international MelMarT-II trial.

A community fundraising campaign has donated $100,000 to a clinical trial investigating melanoma that has spread to the brain.

MASC Trials and Melanoma Patients Australia have launched Self-Skin Checks, No Regrets, an Australian first campaign targeting rural and regional Australians 60+ to regularly check their skin.

An Australian-led trial is now gathering melanoma experts from around the world to contribute results from 3,000 patients to determine the optimal surgical excision margin for melanoma of the skin.

Leading Merkel cell carcinoma expert, Dr Wen Xu, recently presented two Australian clinical trials at the 2nd International Symposium of Merkel Cell Carcinoma in Seattle, USA.

The I-MAT clinical trial is giving patients with early-stage Merkel cell carcinoma an immunotherapy drug after their initial surgery and / or radiotherapy for the cancer to improve their cure rates.

A new innovative clinical trial hopes to find a novel treatment combination for patients who have developed metastatic Merkel cell carcinoma.

The new SiroSkin clinical trial is exploring whether a simple topical cream applied to the face can reduce incidences of skin cancer in organ transplant recipients.

A new editorial publication states that Keratinocyte (skin) cancer is the most common form of human cancer, yet limited treatment advances have been made in the past 10 years and few quality clinical trials have been published, particularly from Australia.